Lineage Cell Therapeutics (LCTX) Revenue (2010 - 2026)
Lineage Cell Therapeutics (LCTX) revenue from Jun 30, 2010 to Mar 31, 2026. The TTM Lineage Cell Therapeutics (LCTX) revenue is $15M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Lineage Cell Therapeutics (LCTX) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +54.71% |
| 3 Years TTM | +6.54% |
| 5 Years TTM | +53.96% |
| 10 Years TTM | +6.54% |
| All Time TTM | +13.12% |
Annual Revenue change of Lineage Cell Therapeutics (LCTX)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $1.73M | -88.12% |
| 2025 | $15M | +53.26% |
| 2024 | $9.50M | +6.15% |
| 2023 | $8.95M | -39.12% |
| 2022 | $15M | +238.71% |
| 2021 | $4.34M | +137.16% |
| 2020 | $1.83M | -48.01% |
| 2019 | $3.52M | -29.46% |
| 2018 | $4.99M | +44.22% |
| 2017 | $3.46M | -41.55% |
| 2016 | $5.92M | -15.91% |
| 2015 | $7.04M | +34.35% |
| 2014 | $5.24M | +18.28% |
| 2013 | $4.43M | +13.01% |
| 2012 | $3.92M | -11.51% |
| 2011 | $4.43M | +19.41% |
| 2010 | $3.71M | +92.23% |
| 2009 | $1.93M | N/A |
Comparison Lineage Cell Therapeutics (LCTX) five years revenue CAGR with competitors
Lineage Cell Therapeutics (LCTX) five years revenue CAGR is 54.06%.